Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 1c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q4 EPS of ($1.25), $0.01 better than the analyst estimate of ($1.26).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue